• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Press releases

The Global Chagas Disease Coalition stages high-level event to encourage increased access to diagnosis and treatment of patients fighting Chagas disease

Mexico City, Mexico — 10 Aug 2014

Of the 8 million people infected in the world, 1 million are Mexican
At the 2014 International Congress of Parasitology (ICOPA), the Global Chagas Disease Coalition launched the event “Let’s Raise Our Voice” to alert the world that of the 8 million patients infected with Chagas disease, 99% have not been treated. The aim of this event is to promote an alliance among governments, civil society, doctors, researchers, and patients to discuss simple actions that can be taken to boost patient access to diagnosis and treatment.
[Español] [Português]

Recent data from the Pan American Health Organization (PAHO) reveals that more than 1 million people are infected with Chagas disease in Mexico, with 30 million at risk of contracting the disease. In the country each year, 7,700 new cases occur, with 1,100 children born with this disease.[1]

At the event, the Global Chagas Disease Coalition, along with researchers, patients, neglected-disease experts, and government representatives, will collectively assess a series of measures for patient diagnosis and treatment for Chagas disease, ensuring quality and access.

Treatment access is not only the responsibility of the government, but also civil society. Doctors must identify people at risk and follow up on treatment recommendations for patients with acute and indeterminate chronic Chagas disease, as recommended by the World Health Organization (WHO). Civil society organizations should raise awareness about Chagas treatment, promoting it, actively engaging to find a solution, and providing support to those who most need it. By joining efforts, a healthier and more equitable future can be achieved for the 8 million people who suffer from Chagas disease.

During the event, the artist Shelly Xie will perform a storytelling performance with sand art. A video will follow to explain the figures of the disease and the need for urgent treatment.

The Global Chagas Disease Coalition was launched in New York in December 2012. Its objective is to promote access to diagnosis and treatment for patients with Chagas and to encourage global efforts to develop new tools to fight this disease. It is made up of civil society organizations including the Drugs for Neglected Diseases initiative (DNDi), Barcelona Institute for Global Health (ISGlobal), Mundo Sano Foundation, CEADES, Sabin Vaccine Institute, Baylor College of Medicine, and Texas Children ́s Hospital.

The Global Chagas Disease Coalition invites everyone to take part and join efforts to contribute and exchange and gain knowledge. The coalition is open to scientific opinion-leaders, the pharmaceutical industry, patients, and everyone who is an active player in the community and affected by Chagas disease.

Participants:

  • Pablo Kuri Morales, Health Secretary, Mexico;
  • Bernard Pécoul, Executive Director, DNDi;
  • Dr. Tamara Mancero, Pan American Health Organization, Mexico (tbc);
  • Igor Almeida, University of Texas; and
  • Elvira Idalia Hernandéz Cuevas, Mexican Association of People Affected by Chagas Disease, AMEPACH.

For more information on the Global Chagas Disease Coalition organizations:

  • Drugs for Neglected Diseases Iniciativa (DNDi) – www.dndial.org
  • Institute for Global Health (ISGlobal) – www.isglobal.org
  • Healthy World Foundation – www.mundosano.org
  • CEADES – www.ceadesbolivia.org
  • Sabin Vaccine Institute – www.sabin.org
  • Baylor College of Medicine and Texas Children ́s Hospital – www.texaschildrens.org; https://www.bcm.edu/

Media Contacts in Mexico:

Catalina de la Puente – Global Chagas Disease Coalition Coordinator – chagas@chagascoalition.org – +54 92214631573

Daniel Salman – DNDi Communication Analyst – dsalman@dndi.org – +55 21 9811 2798

Betina Moura – DNDi Communication Manager – bmoura@dndi.org – +55 21993710925



[1] PAHO: Quantitative estimation of Chagas disease in America. Pan American Health Organization Montevideo, Uruguay, 2006. OPS/HDM/CD/425-06.

Policy advocacy Partnership Strengthening Capacities Chagas disease

Read, watch, share

Loading...
Publications
15 Jul 2025

DNDi 2024 Annual Report

Healthcare worker attending a training
Press releases
10 Jul 2025

New HIV project in the DRC brings life-saving care closer to people with advanced HIV disease

Woman working in a laboratory
News
10 Jul 2025

LEO Foundation partners with DNDi to develop breakthrough drug discovery model for mycetoma 

Press releases
1 Jul 2025

Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment  

Press releases
13 Jun 2025

Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries

Press releases
13 Jun 2025

K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases

News
10 Jun 2025

Bringing life-saving care closer to people living with HIV in Kinshasa 

News
6 Jun 2025

DNDi is partnering with Médecins Sans Frontières South Asia for the Without Borders Media Fellowship 2025 

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License